Middle and lower esophageal clinical analysis of 258 cases.doc

 PAGE \* MERGEFORMAT 9 Middle and lower esophageal clinical analysis of 258 cases On: Sun Wenhui, Luoming Yuan, Zhen Zhang, Sheng Li [Abstract] Objective: To understand the impact of risk factors for esophageal cancer staging, chemotherapy combined with clinical comprehensive therapy. Methods: A retrospective analysis of January 2001 -2006 in December under the chest were treated 258 cases of esophageal cancer clinical pathological data, all the patients without preoperative chemotherapy and radical surgery of esophageal cancer directly, according to UICC97 TNM staging phases. Results: 159 cases of breast cancer section, 99 cases of thoracic cancer. The average length of barium (4.87 +-2.33cm, the average length of surgery (5.28 +-2.35cm. Univariate analysis showed that the length of esophageal lesions, pathological type, location and clinical stage (P lt;0.05), multivariate analysis showed that lesion length more than 5 cm in the lower esophagus and esophageal cancer risk factors in late clinical stage (P lt;0.05). Conclusion: making movies than the actual length of esophageal cancer on the long, length and location of esophageal lesions associated with clinical stage. [Keywords:] the length of esophageal tumor stage Tumor Esophageal cancer is common in China, the prognosis is poor, 5-year survival rate is only about 25% [1-2]. Surgery is the middle and lower section of the main treatment for esophageal cancer, but recent research has found that many patients with esophageal cancer treatment when advanced stage, has lost the opportunity to obtain radical surgery, combined with esophageal cancer occur in the elderly, its poor ability to tolerate surgery, when diagnosis can not be radical surgery for these patients, radiotherapy combined with chemotherapy comprehensive treatment has become the first choice. However, due to the lack of guidance pathology, chemotherapy is not currently clear indication. our hospital in January 2001 -2006 surgery in Dec